Masonic Cancer Center, University of Minnesota
| Date | Speaker |
| September 25, 2003 Sequence effects on the formation of DNA-carcinogen adducts | Natalia Tretyakova, PhD Assistant Professor of Medicinal Chemistry, University of Minnesota Cancer Center |
October 23, 2003 Using combinatorial and evolutionary strategies for biosynthetic pathway engineering
|
Claudia Schmidt-Dannert, PhD Assistant Professor, Biochemistry, Molecular Biology, and Biophysics, University of Minnesota |
November 13, 2003 Smoking and osteoblast function: What we know and where do we go with it? |
Rajaram Gopalakrishnan, BDS, PhD Assistant Professor, Oral and Maxillofacial Pathology, University of Minnesota School of Dentistry |
| December 18, 2003 DNA Repair and Breast Cancer | Myron Gross, PhD Assistant Professor, Laboratory Medicine and Pathology, University of Minnesota |
February 17, 2004 Understanding the Difference in Tumor Susceptibility to Butadiene Using DNA and Protein Adducts |
Gunnar Boysen, PhD University of North Carolina at Chapel Hill, Department of Environmental Science and Engineering |
February 19, 2004 Synthesis of Acetaldehyde-Formed Oligonucleotide Cross-links and Their Irreversible Analogs |
Yanbin Lao, PhD Candidate Hecht Lab, Cancer Center, University of Minnesota |
March 11, 2004 Kinetic "Misbehavior" of Drug Metabolizing Enzymes ("We're not in Kansas anymore, Toto") |
Professor Timothy S. Tracy, PhD Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota |
May 20, 2004 Inactivation of P450s 2B1, 2B2 and 2B4 by tert-butyl 1-methyl-2-propynyl ether |
Linda von Weymarn, Ph.D., Postdoctoral Fellow, Department of Pharmacology, University of Michigan |
June 17, 2004 Cancer Chemoprevention: Metabolically Stable Analogs of
Inositol Phosphates |
Shana J. Sturla, Ph.D.
Assistant Professor, University of Minnesota, Department of Medicinal Chemistry, Cancer Center |